Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals Inc (TSE:CPH)
:CPH
RESEARCH TOOLSreports
Earnings Data
Report Date
Aug 07, 2025Before Open (Confirmed)
Period Ending
2025 (Q2)Consensus EPS Forecast
0.22Last Year’s EPS
0.16Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a strong growth narrative driven by the Natroba acquisition and Canadian product portfolio, leading to significant revenue and EBITDA growth. However, this was somewhat offset by declines in licensing revenue, particularly from Absorica, and increased expenses. The company's strategic debt repayment and pursuit of growth opportunities provide a balanced outlook.Company Guidance -
Q2 2025
Strong Revenue Growth
Total net revenue increased by 105% to $12 million in Q1 2025 compared to the same period in 2024, largely due to the acquisition of the Natroba business.
Natroba Business Performance
Natroba generated $6.7 million in revenue with a gross margin of approximately 87%, positioning the business well for upcoming warmer months.
Canadian Product Portfolio Growth
Canadian product revenue increased by 41% compared to the same quarter in the prior year, contributing to overall product revenue growth.
Adjusted EBITDA Increase
Adjusted EBITDA rose by 73% to $6.2 million due to the Natroba acquisition and growth in the Canadian product portfolio.
Debt Repayment
A repayment of $15 million was made on the revolving credit facility, reducing the outstanding debt to $25 million.
TSE:CPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:CPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | C$14.42 | C$13.91 | -3.54% |
Mar 18, 2025 | C$11.98 | C$13.45 | +12.27% |
Nov 07, 2024 | C$15.54 | C$13.88 | -10.68% |
Aug 08, 2024 | C$13.81 | C$14.43 | +4.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cipher Pharmaceuticals Inc (TSE:CPH) report earnings?
Cipher Pharmaceuticals Inc (TSE:CPH) is schdueled to report earning on Aug 07, 2025, Before Open (Confirmed).
What is Cipher Pharmaceuticals Inc (TSE:CPH) earnings time?
Cipher Pharmaceuticals Inc (TSE:CPH) earnings time is at Aug 07, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CPH EPS forecast?
TSE:CPH EPS forecast for the fiscal quarter 2025 (Q2) is 0.22.